One Health in Chad

The Support Project for the Health Districts in Chad (PADS - Programme d'Appui aux Districts Sanitaires au Tchad) aims to strengthen the healthcare system. In order to reach people in remote areas such as nomadic populations, PADS applies a 'One Health' approach taking into account both human and animal health.

PADS is a project of the Swiss Agency for Development and Cooperation.

Click here for French version

1st December is World AIDS Day

Swiss TPH is committed to contributing to global efforts controlling HIV/Aids in particular to ensure equity in access to prevention and care including for disadvantaged communities and vulnerable groups.

Learn more

A Milestone in the Fight Against Sleeping Sickness

Fexinidazole is the first all-oral drug against sleeping sickness. Swiss TPH contributed significantly to the development of fexinidazole together with DNDi, Sanofi and many others. Since its foundation 75 years ago, Swiss TPH has been researching sleeping sickness. For instance, it was the first to succeed in breeding tsetse flies under laboratory conditions.

Photo: Swiss TPH 1946

More on fexinidazole

50 years of Papua New Guinea Institute of Medical Research

The Papua New Guinea Institute of Medical Research (PNGIMR), a long-standing partner of Swiss TPH, celebrates its 50th anniversary.

Swiss TPH will take part in the anniversary colloquium to highlight the collaboration between the two institutes and to further strengthen efforts towards malaria elimination.

Read More

Health Care and Management: From Research to Implementation

Do you want to launch a career in international public health?

The Health Care and Management (HCM) course provides participants with the core competencies for understanding and reacting to health challenges at a world-leading institute in global health.

Learn more about the HCM

MBA in International Health Management

Do you want to become a part of a new generation of leaders in global health?

Swiss TPH’s part-time MBA in International Health Management trains future leaders and managers who want to work in multicultural and transdisciplinary settings.

Learn more about the MBA

Why Swiss TPH?

More than 800 employees and students from 79 nations work at Swiss TPH, focusing on infectious and non-communicable diseases, environment, society and health as well as health systems and interventions. They all share the mission to improve population health globally.

12 December is Universal Health Coverage Day

Quality, affordable health care is the foundation for individuals to lead productive and fulfilling lives and for countries to have strong economies.

Universal Health Coverage (UHC) ensures all people can access the quality health services they need without suffering financial hardship.

Today marks the annual rallying point for the growing movement for health for all.

Learn more
14.12.2018 13:00 to 13:45

[NEW TIME] From cardiovascular disease prevention to healthy ageing: a (my) scientific journey

Lecturer: Professor Oscar H. Franco, University of Bern & Institute of Social and Preventive Medicine (ISPM), Switzerland
Location: Swiss TPH, Alpamayo

17.12.2018 17:15 to 18:00

In vitro potency and MoA of next-generation synthetic peroxides against an artemisinin-resilient Plasmodium falciparum isolate

Lecturer: Annabelle Walz
Location: Swiss TPH, Kilimanjaro
Event category: Advances in Infection Biology, Epidemiology and Global Public Health


R. Geigy-Preis 2018 geht an Stella Hartinger-Peña

Die Peruanerin Stella Hartinger-Peña erhält den mit 20'000 CHF dotierten R. Geigy-Preis 2018. Die Basler R. Geigy-Stiftung würdigt damit ihre Verdienste im Kampf gegen... More...


Zehn Jahre Versicherungsmedizin

Seit zehn Jahren wird an der Universität Basel der im deutschsprachigen Raum einzigartige Master-Studiengang in Versicherungsmedizin angeboten. Seit drei Jahren ist die... More...


Daniel H. Paris: Professor für Tropen- und Reisemedizin an der Universität Basel

Prof. Dr. med. Daniel H. Paris, Leiter Departement Medizin am Swiss TPH, wurde auf den 1. Dezember 2018 vom Universitätsrat der Universität Basel zum Associate Professor für... More...


Fexinidazole - First All-Oral Treatment for Sleeping Sickness Approved

The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion of fexinidazole, the first all-oral treatment that has been shown to... More...